Prevalence of gestational diabetes mellitus detected by the national diabetes data group or the carpenter and coustan plasma glucose thresholds
Prevalence of gestational diabetes mellitus detected by the national diabetes data group or the carpenter and coustan plasma glucose thresholds
复制标题
DOI：
10.2337/diacare.25.9.1625
复制
发表时间：
2002-09-01
期刊：
影响因子：
16.2
通讯作者：
Selby, JV
中科院分区：
文献类型：
--
作者：
Ferrara, A;Hedderson, MM;Selby, JV
目的：2000年，美国糖尿病协会提出采用Carpenter和Coustein标准诊断妊娠期糖尿病(GDM)。卡朋特和库斯坦的临界值低于之前推荐的国家糖尿病数据集团(NDDG)的值，并将导致更高的GDM患病率。我们的目标是使用Carpenter和Coustein阈值与NDDG阈值按年龄和种族比较来估计GDM患病率的变化幅度。研究设计和方法-对28,330名14-49岁的妇女进行横断面研究，她们于1996年分娩，是北加州Kaiser Permanente医疗保健计划的成员。结果：共有26,481名(94%)女性接受了50克1小时口服葡萄糖耐量试验的筛查，4,190名妇女在异常筛查后接受了100克3小时口服葡萄糖耐量试验。总体而言，筛查妇女的妊娠期糖尿病患病率按NDDG标准为3.2%(95%可信区间3.0-3.4%)，按卡彭特和库斯坦标准为4.8%(95%可信区间4.5%-5.1%)，根据这两个阈值，均随年龄增长而增加(P<；0.001)。根据NDDG和Carpenter and Coustein标准，年龄调整后的GDM患病率在亚洲分别为5.0%和7.4%，西班牙裔为3.9%和5.6%，非裔美国人为3.0%和4.0%，白人为2.4%和3.8%。年龄较大的女性的比例增量更大
OBJECTIVE - In 2000, the American Diabetes Association proposed the adoption of the Carpenter and Coustan criteria for diagnosis of gestational diabetes mellitus (GDM). The Carpenter and Coustan cutoffs are lower than the previously recommended National Diabetes Data Group (NDDG) values and would result in higher prevalence of GDM. Our aim is to estimate the magnitude of change in prevalence of GDM using the Carpenter and Coustan thresholds as compared with the NDDG thresholds by age and ethnicity.RESEARCH DESIGN AND METHODS - Cross-sectional study of 28,330 women aged 14-49 years who gave birth in 1996 and were members of the Northern California Kaiser Permanente Medical Care Program. Age, ethnicity, screening, and diagnostic test results were assessed from computerized hospitalization and laboratory systems.RESULTS - A total of 26,481 (94%) women were screened using a 50-g, 1-h oral glucose tolerance test, and 4,190 women underwent a diagnostic 100-g, 3-h oral glucose tolerance test after an abnormal screening. Overall, the GDM prevalence among screened women was 3.2% (95% CI 3.0-3.4) by NDDG and 4.8% (95% CI 4.5-5.1) by Carpenter and Coustan criteria, and based on either threshold, it increased with age (P < 0.001). The age-adjusted GDM prevalence by NDDG and Carpenter and Coustan criteria, respectively, was 5.0 and 7.4% in Asians, 3.9 and 5.6% in Hispanics, 3.0 and 4.0% in African-Americans, and 2.4 and 3.8% in whites. Proportional increments were larger in women aged